In order to understand, whether somatic mutations in the KCNJ3 gene are indeed important in clinical settings, will require more, careful and targeted screening and compilation of somatic mutations in tumor samples in the context of histological parameters as well as cancer progression accompanied by pursuing studies in human cancer as well as cancer progenitor cells, in the future. Here, KCNJ3 is linked to cancer.